Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleAlec Machiels
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Alec Machiels: trading record in brief
Alec Machiels, listed as board member, appears in our data through filings on Apellis Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 41 filings; the first trade dates from 14 May 2021 and the latest from 14 May 2026.
Every open-market trade on record is a sale: 4 sales worth €323k. Outside the open market, there are 5 share grants and 31 option exercises.
The record was last updated on 14 May 2026 with a transaction in Apellis Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alec Machiels
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
384,989 sharesCommon StockSEC:0001193125-26-224611:0
7,961 shares0Common StockSEC:0001492422-26-000014:0
6,267 shares0Common StockSEC:0001127602-25-000436:0
3,341 shares0Common StockSEC:0001127602-24-000107:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-027990:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-026081:0
1,250 shares@ US$2.671.1% of flowCommon StockSEC:0001127602-23-024448:0
1,250 shares@ US$2.671.1% of flowCommon StockSEC:0001127602-23-024309:0
49,779 shares@ US$2.6719.4% of flowCommon StockSEC:0001127602-23-021193:0
50,000 shares@ US$2.6719.5% of flowCommon StockSEC:0001127602-23-021137:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-020951:0
1,250 shares@ US$64.7911.7% of flowCommon StockSEC:0001127602-23-020951:1
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-019158:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-016195:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-013129:0
1,250 shares@ US$81.0515.1% of flowCommon StockSEC:0001127602-23-013129:1
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-010957:0
1,250 shares@ US$64.0312.2% of flowCommon StockSEC:0001127602-23-010957:1
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-006189:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-23-001805:0
3,867 shares0Common StockSEC:0000899243-23-000675:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-22-027856:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0000899243-22-036194:0
1,250 shares@ US$2.670.6% of flowCommon StockSEC:0001127602-22-023984:0
1,250 shares@ US$2.670.5% of flowCommon StockSEC:0001127602-22-022540:0
25 of 41 declarations
